Compare drug alternatives

Tremfya® Alternatives

Tremfya®

(Guselkumab)
Tremfya
Prescription Only

Tremfya, an interleukin inhibitor, is indicated for the treatment of plaque psoriasis or psoriatic arthritis in adults. Patients can learn to self-administer Tremfya subcutaneously every eight weeks, and the most common side effects are injection site reactions and an elevated risk of infection.

Tremfya is FDA approved for the following indications: Plaque Psoriasis and Psoriatic Arthritis.

Stelara®

(Ustekinumab)
Stelara
Prescription Only

Stelara is an immunosuppressant medication that targets two inflammatory cytokines, IL-12 and IL-23, which are key contributors to chronic inflammation. For Crohn's disease and ulcerative colitis, Stelara is administered every 8 weeks, and for psoriasis, it is given every 12 weeks. Its most frequently reported side effects are an increased susceptibility to infection, as well as nasopharyngitis, headache, and fatigue.

Stelara is FDA approved for the following indications: Plaque Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis.

Dosage & Administration

Administration
Subcutaneous injection. Learn more.
Subcutaneous injection. Learn more.
Dosing
100 mg at Week 0, Week 4, and every 8 weeks thereafter
45 mg initially and 4 weeks later, followed by 45 mg every 12 weeks for adult Psoriatic Arthritis. Weight-based dosing for pediatric Psoriatic Arthritis
Latin Shorthand
100 mg Week 0, 4, q8w
45 mg Week 0, 4, then 45 mg q12w

Financial Assistance

Copay
$5
$5
Annual Cap
$6,000
Assistance Expiration
End of each calendar year (subject to change or end without notice)
End of each calendar year (subject to change or discontinuation without notice)
Generics
No lower-cost generic available
No lower-cost generic available

Popular alternatives

Relevant Resources

Tremfya
Stelara